Seeking to outpace the market, investors engage in the art of selecting individual stocks. The right picks can play a pivotal role in boosting your wealth.
The price of Nutrien Ltd (NYSE: NTR) closed at $56.83 in the last session, up 1.07% from day before closing price of $56.23. In other words, the price has increased by $1.07 from its previous closing price. On the day, 2.54 million shares were traded. NTR stock price reached its highest trading level at $56.945 during the session, while it also had its lowest trading level at $55.98.
Ratios:
We take a closer look at NTR’s different ratios to gain a better understanding of the stock. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 44.02 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 12.20. For the most recent quarter (mrq), Quick Ratio is recorded 0.89 and its Current Ratio is at 1.41. In the meantime, Its Debt-to-Equity ratio is 0.56 whereas as Long-Term Debt/Eq ratio is at 0.43.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, NTR now has a Market Capitalization of 27678461952 and an Enterprise Value of 41060245504. As of this moment, Nutrien’s Price-to-Earnings (P/E) ratio for their current fiscal year is 15.31, and their Forward P/E ratio for the next fiscal year is 12.41. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 1.96. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.03 while its Price-to-Book (P/B) ratio in mrq is 1.10. Its current Enterprise Value per Revenue stands at 1.599 whereas that against EBITDA is 7.878.
Stock Price History:
The Beta on a monthly basis for NTR is 0.73, which has changed by 0.22000432 over the last 52 weeks, in comparison to a change of 0.1177547 over the same period for the S&P500. Over the past 52 weeks, NTR has reached a high of $65.08, while it has fallen to a 52-week low of $43.69. The 50-Day Moving Average of the stock is -1.17%, while the 200-Day Moving Average is calculated to be 0.77%.
Shares Statistics:
According to the various share statistics, NTR traded on average about 2.61M shares per day over the past 3-months and 2174450 shares per day over the past 10 days. A total of 484.33M shares are outstanding, with a floating share count of 483.03M. Insiders hold about 0.06% of the company’s shares, while institutions hold 75.13% stake in the company. Shares short for NTR as of 1763078400 were 4489477 with a Short Ratio of 1.73, compared to 1760486400 on 5161445. Therefore, it implies a Short% of Shares Outstanding of 4489477 and a Short% of Float of 0.9299999999999999.
Dividends & Splits
The forward annual dividend rate for NTR is 2.18, which was 2.175 in the trailing 12 months. Against a Trailing Annual Dividend Yield of 0.03868042. The stock’s 5-year Average Dividend Yield is 3.31.
Earnings Estimates
The market rating for Nutrien Ltd (NTR) is a result of the insights provided by 17.0 analysts actively involved in the assessment.The consensus estimate for the next quarter is $0.56, with high estimates of $0.85 and low estimates of $0.12.
Analysts are recommending an EPS of between $5.7 and $4.5 for the fiscal current year, implying an average EPS of $4.7. EPS for the following year is $4.58, with 23.0 analysts recommending between $5.85 and $3.65.
Revenue Estimates
According to 7 analysts, . The current quarter’s revenue is expected to be $5.28B. It ranges from a high estimate of $5.45B to a low estimate of $5.09B. As of . The current estimate, Nutrien Ltd’s year-ago sales were $4.86BFor the next quarter, 7 analysts are estimating revenue of $5.19B. There is a high estimate of $5.29B for the next quarter, whereas the lowest estimate is $5.07B.
A total of 17 analysts have provided revenue estimates for NTR’s current fiscal year. The highest revenue estimate was $27.63B, while the lowest revenue estimate was $25.9B, resulting in an average revenue estimate of $26.45B. In the same quarter a year ago, actual revenue was $25.02BBased on 17 analysts’ estimates, the company’s revenue will be $26.67B in the next fiscal year. The high estimate is $28.46B and the low estimate is $25.68B.
